Advertisement

Advertisement

Most Read Stories
Immunotherapy Improves Survival in a Subset of Patients With Metastatic Triple-Negative Breast Cancer
Trifluridine/Tipiracil in Heavily Pretreated Metastatic Gastric Cancer
FDA Approves Pembrolizumab for Hepatocellular Carcinoma Previously Treated With a Kinase Inhibitor
Final Analysis of SWOG POEMS: Goserelin and Chemotherapy in Breast Cancer
Weighing the Cost and Value of CAR T-Cell Therapy
Can Patients Use Topical Skin Creams During Radiation Therapy?
Prevalence of Lynch Syndrome in Solid Tumors According to Microsatellite Instability Status
Durvalumab With or Without Tremelimumab in Recurrent or Metastatic HNSCC With Low/No PD-L1 Expression
Activity of Vemurafenib in BRAF V600–Mutant Gliomas
A Love of Older Patients With Cancer Drives a Career Path for Arti Hurria, MD, FASCO
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
PERSIST-5: 5-Year Adjuvant Imatinib in Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor
2018 Palliative Care: Immunotherapy-Related Adverse Events May Be More Common Than Initially Reported
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
Has the Promise of Precision Medicine Been Oversold?
Increased Survival in Patients With Metastatic NSCLC Receiving Treatment in Academic vs Community Centers
Patient-Reported Cosmetic Outcomes With Radiotherapy in Early Breast Cancer
Novel Physician-Driven Practice Model Offers Alternative to Community Oncologists
2018 Palliative Care: Can an AI-Based App Help Manage Cancer-Related Pain?
Brigatinib Improves Outcomes Over Crizotinib in ALK-Positive Non–Small Cell Lung Cancer

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.